Mode
Text Size
Log in / Sign up
N/A N=180 Randomized Single-blind Treatment

Fibre-optic Guided Tracheal Intubation Through SADs

Intubation; Difficult or Failed · Laryngeal Masks · Airway Management

Enrolled (actual)
180
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Total Intubation Time to Perform Fibreoptic Intubation — 54.3; 52.0 seconds

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
I-gel (Device); LMA Protector (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Primary completion
Mar 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Total Intubation Time to Perform Fibreoptic Intubation
54.3; 52.0
SECONDARY
SAD Insertion Time
19.4; 25.4
SECONDARY
Number of Attempts at the SAD Placement
SECONDARY
Number of Participants With Ease of Placement of the SAD
86; 37; 6; 44; 0; 5
SECONDARY
Number of Participants With First and Second Attempt at Tracheal Intubation
90; 84; 2; 2
SECONDARY
Number of Participants With Quality of the View of the Vocal Cords Seen Through the SAD
71; 72; 20; 14; 1; 0
SECONDARY
Time to Carinal View
23.4; 21.9
SECONDARY
Number of Participants With Type of Airway Maneuvers Performed During Tracheal Intubation,
38; 23; 54; 63

Summary

The study aims to establish which of the two second generation Supraglottic Airway Devices, the I-gel or the the laryngeal ask airway (LMA) Protector, is best suited to be used as a conduit to fibreoptic bronchoscope assisted tracheal intubation. The primary outcome of this will be the time to complete the tracheal intubation.

Eligibility Criteria

Inclusion Criteria

  • All patients aged above 18, presenting for elective surgical procedure, where a supraglottic airway device can be used and left in place throughout the duration of surgery and requiring tracheal intubation

Exclusion Criteria

  • Patients who are do not wish to take part
  • Patients with class II obesity (BMI >40)
  • Patients below 18 years of age
  • American Society of Anaesthesiologists (ASA 3, 4 and 5)
  • Patients with mouth opening of less than 3 cm
  • Patients deemed to require awake intubation
  • Surgery involving head and neck region
  • Surgery requiring prone position
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03118596). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search